- Country: USA
- Summary: Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
- UST Ref No: 127076712
- Deadline: 19 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: ARPA-H-SOL-25-122
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Advanced Research Projects Agency for Health (ARPA-H) Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program envisions a future where patients can opt for one-time therapeutic interventions designed to slow, reverse, or cure disease, harnessing revolutionary technologies and a rapidly evolving understanding of the genetic underpinnings of the biological processes that lead to disease.
Interested parties are invited to review the attached THRIVE Innovative Solutions Opening (ISO) ARPA-H -SOL-25-122.For detailed information regarding Proposers' Day review Special Notice (SN) ARPA-H-SN-25-131.
Solution summaries are due October 31, 2025, 11:59 PM ET.
For more information about THRIVE, please visit:https://arpa-h.gov/explore-funding/programs/thrive - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTreating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE). This tender is published on USARFP under UST Ref No: 127076712 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-19.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
